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ABSTRACT 
ROLE OF THE NUCLEAR MATRIX PROTEIN C1D IN REGULATION OF 
TRANSCRIPTION 
Dilhan Öncel 
M.S in Molecular Biology and Genetics 
Supervisor: Assist. Prof. Uğur Yavuzer 
August 2001, 88 pages 
 The nuclear matrix protein C1D is an activator of DNA-dependent protein kinase (DNA-
PK), which is involved in non-homologous end joining and V(D)J recombination. Moreover, the 
nuclear matrix proteins C1D was shown to be phosphorylated in vitro by DNA-PK and its mRNA 
and protein levels have been demonstrated to be induced upon γ-irradiation. The available 
information suggests that C1D may play a role in DNA DSB-response pathways by targeting DNA-
PKcs to nuclear matrix and matrix-associated DNA where DNA-PK may regulate several cellular 
processes. In an attempt to identify the biological function of C1D, the yeast two-hybrid system 
was employed and C1D was found to interact with a partial clone of TAFI 48, which is a subunit of 
the promoter selectivity factor SL1 required for the accurate initiation of transcription from the 
human ribosomal promoter. The possibility of an interaction between C1D and TAFI 48 was 
potentially important as DNA-PK was found to be capable of repressing Polymerase I transcription 
in vitro. 
 In this study, it was shown that C1D and TAFI 48 interact specifically in yeast, in vitro and 
in mammalian cells. It ıs belıeved that this interaction could have potential roles in regulating the 
repression of transcription from rDNA by DNA-PK in response to DNA double-strand breaks. 
 
 Key Words: C1D, DNA-PK, DNA Double-strand break, TAFI 48.  
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ÖZET 
NÜKLEER MATRİKS PROTEİNİ C1D’NİN TRANSKRİPSİYONUN REGÜLE 
EDİLMESİNDEKİ ROLÜ 
Dilhan Öncel 
Moleküler Biyoloji ve Genetik Yüksek Lisans 
Tez Yöneticisi: Assist. Prof. Uğur Yavuzer 
Ağustos 2001, 88 sayfa 
 
Nükleer matriks proteini C1D, DNA uçlarının doğrudan bağlanmasında ve  V(D)J 
rekombinasyonunda rol oynayan DNA bağımlı  protein kinazın (DNA-PK) bir aktivatörüdür. 
Ayrıca nükleer matriks proteini C1D’nin , DNA-PK tarafından in vitro şartlarda fosforlanabildiği 
ve γ irradyasyonu sonrası mRNA ve protein seviyesinin arttığı gösterilmiştir. Elimizdeki bilgiler  
çift sarmal DNA kırıklarına tepki olarak C1D’nin DNA-PK’yı nükleer matrikse veya matrikse 
ilintili DNA’ya, birçok hücresel olayı kontrol etmek amacıyla yönlendirebileceğini önermektedir.  
C1D’nin biyolojik fonksiyonunu bulmaya yönelik bir denemede maya ikili hibrid sistemi 
uygulanmış ve C1D’nin insan ribosomal promotorlarından transkripsiyonun doğru başlaması için 
gerekli olan SL1’nın bir alt ünitesi olan TAFI 48’in bir kısmını kodlayan bir klon ile etkileştiği 
bulunmuştur. DNA-PK Polimeraz I transkripsiyonunu in vitro şartlarda bloke edebildiği için, C1D 
ve TAFI 48’in etkileşme ihtimali potensiyel bir önem arz etmektedir. 
 Bu çalışmada, C1D ve TAFI 48’in mayada, in vitro şartlarda ve memeli hücrelerinde 
spesifik olarak etkileşime girdiği gösterilmiştir. Bu etkileşimin  çift sarmal DNA kırıklarının 
etkisiyle DNA-PK tarafından rDNA’dan transkripsiyonun bloke edilmesinin düzenlenmesinde  
potansiyel rolleri olduğu düşünülmektedir. 
 
Anahtar Kelimeler: C1D, DNA-PK, çift sarmal DNA kırıkları, TAFI 48. 
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INTRODUCTION
21.  DNA DAMAGE
Cells are constantly under threat from the cytotoxic and mutagenic effects of DNA
damaging agents.  These agents can either be exogenous or formed within cells.
Environmental DNA-damaging agents include UV light and ionizing radiation, as well as a
variety of chemicals contained in foodstuff and cigarette smoke.  Endogenous damaging
agents include methylating species and the reactive oxygen species that arise during
respiration.
These DNA damaging agents may lead to two general types of abnormalities that, if
left unrepaired, will eventually lead to mutation, which is a permanent change in DNA
sequence.  The first class of mutations involve single base changes, which does not cause a
major structural distortion on the DNA.  The second class on the other hand, induces
distortions on the structure of DNA, which may interfere with transcription and replication
processes, with deleterious effects on the cell survival.
To ensure the genetic stability and cell survival, cells are equipped with
mechanisms to repair these structural abnormalities.  The first reaction in response to DNA
damage is to arrest the cell cycle to provide enough time for the repair process.  This event
also prevents transmission of the damaged DNA to the next generations.  Following the
cell cycle arrest, repair process is initiated, using one of the many repair pathways differing
according to the type of damage.  However, if the damage is beyond repair, then cells
choose to commit suicide (apoptosis) to prevent the cell being divided with the heavily
mutated DNA.  In general terms there are three categories of DNA repair.  First one is
excision repair, which includes both base and nucleotide excision repair.  The incorrect or
3damaged base is removed either as a base (base excision) or as an (oligo)nucleotide
(nucleotide excision), the single-stranded gap resulting from the excision is filled by a
polymerase using the information of the other strand.  Second one is mismatch repair,
which relies on the parental strand to correct misincorporation of nucleotides during
replication and heteroduplex regions produced by genetic recombination.  The third
category is double-strand break repair and unlike the other two pathways, presence of
homology regions is not necessarily required for this type of DNA repair.
1.1.  DNA Double-Strand Break (DSB)
The DNA double-strand break (DSB) is one of the most dangerous lesions that can
occur within the cell.  The presence of an unrepaired DSB will trigger the DNA-damage
response systems of a cell to arrest its progression through the cell cycle and, sometimes, to
cause apoptotic cell death (Huang et al. 1996).  If repaired improperly, they can lead to
chromosome translocations and cancer.
DNA DSBs can arise by exogenous agents such as ionizing radiation (IR) and
certain chemotherapeutic drugs, or as a consequence of some physiological events such as
endogenously generated reactive oxygen species, mechanical stress on the chromosomes,
or when DNA replication forks encounter DNA single-strand breaks or other type of
lesions.  DNA DSBs are also generated to initiate recombination between homologous
chromosomes during meiosis and occur as intermediates during developmentally regulated
rearrangements, such as V(D)J recombination and immunoglobulin class-switch
recombination (Smider and Chu 1997).
4There are two general types of DSB repair: homologous recombination (HR) and
non-homologous end joining (NHEJ).
1.1.1.  Homologous Recombination
 There are several types of homologous repair: gene conversion, break-induced
replication and single-strand annealing.  After a double-strand break (DSB) is created, the
ends are resected and one of the 3' single-stranded ends can invade an intact template.
Strand invasion requires the participation of the Rad51p strand exchange protein and a
number of associated proteins, including Rad52p, Rad54p and Tid1p.  During meiosis,
these recombination proteins are joined by a second strand-exchange protein, Dmc1p.
Strand invasion is believed to establish a modified replication fork, in which both leading
and lagging-strand DNA synthesis occurs.  As new DNA synthesis proceeds, branch
migration displaces the two newly synthesized strands.  The four main outcomes of
homologous repair can be summarized as follows: (a) If the replication fork encounters the
other end of the DSB, an intermediate containing two Holliday junctions can be formed,
allowing gene conversions to be resolved both with and without crossing-over. (b) If the
strands are completely displaced or if the leading strand pairs with the second end of the
DSB, a simple synthesis-dependent strand annealing (SDSA) will occur, producing gene
conversions without crossing-over (Pâques and Haber 1999; Fishman-Lobell et al. 1992).
(c) If the second end of the DSB fails to engage, replication can proceed all the way to the
end of the chromosome (or until it encounters a converging replication fork).  This process
is known as break-induced replication (BIR) (Bosco and Haber 1998; Morrow et al. 1997).
(d) If resection proceeds far enough to expose complementary strands of homologous
5sequences flanking a DSB, repair can occur by single-strand annealing (SSA), leading to a
deletion of all intervening sequences (Sugawara et al. 2000).
1.1.2.  Non-Homologous End Joining (NHEJ)
DSB ends can be repaired by several nonhomologous repair mechanisms, in which
the DNA ends are joined with little or no base pairing at the junction (Moore and Haber
1996; Jeggo 1998).  NHEJ of two DNA ends does not require an undamaged partner and
does not rely on extensive homologies between the two recombining ends. In this process,
sometimes after limited degradation at the termini, the two ends are ligated together.
Consequently, NHEJ is prone to error, and small sequence deletions are usually introduced.
End joining in yeast and mammals requires the same core set of proteins: the DNA
end-binding proteins Ku70p and Ku80p, as well as DNA ligase IV and its associated Xrcc4
protein.  Vertebrate cells also require DNA-PKcs, which together with the Ku70 and Ku80
forms the DNA-PK holoenzyme. DNA-PK is a nuclear serine/threonine kinase with a well-
established role in NHEJ. Interestingly, no homologue has been identified in S.cerevisiae
for DNA-PKcs.  In mammals, the carboxy-terminal portion of Ku80 is essential for the
activation of DNA-PK and this region is distinct from the one that interacts with Ku70
(Singleton et al. 1999).  The requirement for this carboxy-terminal region in kinase
activation is consistent with the absence of an analogous Ku80 carboxy-terminal tail in
S.cerevisiae, which also lacks a homologous DNA-PKcs protein.
Although NHEJ has been considered the major pathway of DSB repair in
mammalian cells, these two processes are in competition with each other.  Very little is
known in general about how cells choose which pathway to use.   It has been suggested that
6two DNA end-binding proteins, Rad52 and Ku compete for binding to DSBs and channel
the repair of DSBs into HR and NHEJ, respectively (Van Dyck et al. 1999; Haber 1999).
1.2.  Involvement of DNA-PK in NHEJ
The nuclear serine/threonine kinase, DNA-PK, is comprised of a catalytic subunit
termed DNA-PKcs and two DNA binding componets, Ku70 and Ku80.  The involvement
of DNA-PK in DSB repair became evident from analyses involving a specific series of
mutant rodent cell lines (Jackson and Jeggo 1995).  Early studies in these mutant cells
found them to be hypersensitive to irradiation (IR) and radiomimetic agents with little or no
cross sensitivity to other types of DNA damaging agents and showed them to be defective
in the repair of chromosomal DNA DSBs.  Screening of these x-ray sensitive cell lines led
to the identification of three distinct complementation groups, termed IR4, IR5, and IR7,
with defects in both DSB repair and V(D)J recombination.  Since efforts were undertaken
to complement these rodent cell lines with human genes, the genes for the
complementation groups were designated XRCC for x-ray cross complementing
(Thompson and Jeggo 1995; Zdzienicka 1995).  Later it was shown that, cells of IR5 and
IR7 harboured inactivating mutations in the genes of Ku80 and DNA-PKcs, respectively,
and that inactivation of Ku80 leads to a dramatic destabilization of both itself and Ku70
(Errami et al. 1996, 1998a, 1998b; Blunt et al. 1996; Danska et al. 1996; Araki et al. 1997;
Singleton et al. 1997; Peterson et al. 1997; Fukumura et al. 1998; Priestley et al. 1998).  It
was therefore concluded that mutations in Ku80 and DNA-PKcs lead to IR sensitivity, that
XRCC5 and XRCC7 encode Ku80 and DNA-PKcs respectively, and that DNA-PK is a
crucial component of the mammalian DNA DSB repair apparatus (Priestley et al. 1998).
7Although among these mutant cell lines, a mutation for Ku70 was not identified, later a
group of cell line termed IR6 was established by knocking-out the Ku70 gene and was
shown that these cells also carry the same phenotype as IR5 and IR7 and was defective in
DNA-PK activity.  Therefore, it was concluded that Ku70 is encoded by XRCC6 (Gu et al.
1997).
Although the precise molecular mechanism underlying the role of DNA-PK in DSB
repair is not yet known, in the light of biochemical and genetics studies, some hypotheses
have been proposed.  The heterodimer of Ku80 and Ku70 binds with high affinity to DNA
ends, suggesting an early role in damage recognition, processing or both. Ku binding
probably protects the DNA ends from degradation until end joining is completed (Liang
and Jasin 1996).  In addition, Ku protein might play a role in juxtapositioning of two DNA
ends since it can transfer between DNA fragments with complementary overhangs (Bliss
and Lane 1997).  On binding to the DNA ends, Ku may recruit DNA-PKcs.  Synapsis of
the two DNA ends might be mediated by two independent DNA binding sites on DNA-PK
or by the association of two DNA-PK molecules (Chu 1997).  The molecular architecture
of DNA-PKcs suggests a structural role for the protein in the rejoining process.  It has a
potential DNA-binding groove and an enclosed cavity with three apertures through which
single-stranded DNA could pass (Leuther et al. 1999).  These findings are consistent with
DNA-PKcs mediating the alignment of short stretches of single-stranded DNA prior to
ligation.
DNA-PK has also an autophosphorylation activity (Chan and Lees-Miller 1996).  It
is hypothesized that this phosphorylation occurs in trans, so that the kinase assembled on
one DNA end phosphorylates the other DNA-PK molecule assembled on the other DNA
8end.  Activity in trans would regulate the kinase activity so that processing of the DNA
ends would occur only after synapsis of the two ends is accomplished (Chu 1997).
The autophosphorylation also causes the dissociation of the catalytic subunit from
Ku (Chan and Lees-Miller 1996), and Ku acquires helicase activity (Cao et al. 1994; Tuteja
et al. 1994).  It is postulated that this helicase activity unwinds DNA ends in vivo so that
exposed regions of microhomology can anneal by base pairing (Chu 1997).  The unpaired
DNA flaps could then be removed either by an exonuclease or a flap endonuclease.  Gaps
are then filled in by a DNA polymerase and the nicks sealed by ligase to complete the end-
joining process (Figure 1, Chu 1997).
Figure 1.1: Model for the role of Ku and DNA-PKcs in nonhomologous end joining.
9Once positioned at the DNA DSB, Ku and DNA-PKcs might then recruit other
NHEJ factors essential for the repair process.  It is possible that, as being a kinase, DNA-
PK may also regulate the activity of the proteins in this repair complex by phosphorylation.
In this regard, the plausible targets for DNA-PK include the single-stranded binding protein
RPA (replication protein A), the DNA ligase IV cofactor Xrcc4, Ku, and DNA-PKcs itself
(Karran 2000).  However, DNA-PK has also been shown to phosphorylate many
transcription factors, including the tumour suppressor p53 in vitro, which indicates that
DNA-PK may also be involved in regulation of transcription. Indeed, DNA-PK has been
demonstrated to repress Polymerase I transcription in vitro (Kuhn et al. 1995).  All these
findings suggest that DNA-PK may also regulate transcription at the sites of DNA damage
and may be by repressing transcription and recombination, to allow enough time for the
repair machinery to perform its function (Zhu et al. 1996).
2.  EUKARYOTIC TRANSCRIPTION
In eukaryotes, transcription is carried out by three different RNA polymerases,
RNA polymerase I, II, and III, each of which is dedicated to the transcription of different
sets of genes.  The genes in each class contain characteristic promoters, which often consist
of two types of elements: the basal promoter elements and the modulator promoter
elements.  The basal promoter elements are sufficient to determine RNA polymerase
specificity and direct low levels of transcription, whereas the modulator elements enhance
or reduce the basal levels of transcription.  None of the RNA Polymerases can recognize its
target promoters directly.  Instead, basal promoter elements are first recognized by specific
transcription factors, which then recruit the correct RNA polymerase.
10
The RNA Polymerase I promoters, which direct transcription of the large rRNA
genes, do not contain a TATA box (Reeder 1992).  The human rRNA promoters are instead
composed of a core element that overlaps the transcriptional start site and an upstream
control element (UCE) located upstream of position –100 that stimulates transcription 10-
to 100-fold.
RNA polymerase II promoters can be divided into two large classes: the mRNA
promoters and the snRNA promoters.  The mRNA promoters can in turn be divided into
two classes depending on whether or not they contain a TATA box.  The basal TATA-box
containing mRNA promoters may consist of either the TATA box alone or the TATA box
and an initiator sequence (Inr) that spans the transcriptional start site.  The basal TATA-
less mRNA promoters consist of just the Inr.  Both TATA box and Inr appear to recruit the
TBP-containing complex TFIID.  TBP (TATA-box Binding Protein) on its own can,
however, replace the TFIID complex to direct basal levels of transcription from TATA-
containing promoters in vitro, suggesting that direct interactions exist between TBP and
components of the basal transcription machinery.
The basal RNA polymerase II snRNA promoters consist of a proximal sequence
element (PSE), which is also present in RNA polymerase III snRNA promoters.
Transcription from these promoters also requires TBP, which is recruited by the PSE.
The RNA polymerase III promoters have been divided into three classes
(Geiduschek and Kasavetis 1992).  Classes 1 and 2 are gene-internal TATA-less promoters
and consist of the internal control region (ICR) of 5S rRNA genes and the A and B boxes
of tRNA and 7SL genes, Alu sequences, and viral genes such as the Ad2 VAI and VAII
genes.  Class 3 promoters are found in a number of vertebrate snRNA and cytoplasmic
11
RNA genes, including the U6, 7SK, hY1 and hY3, H1, and MRP/Th RNA genes
(Hernandez 1992).  They are located entirely upstream of the gene-coding sequences and
are similar to the RNA polymerase II snRNA promoters except for the presence of a TATA
box, which determines the RNA polymerase III specificity of the promoter.  Transcription
from both the TATA-less and TATA-containing RNA polymerase III promoters requires
TBP, although in different complexes.
2.1.  Regulation of RNA Polymerase I and Connection with DNA-PK
Human ribosomal RNA synthesis by RNA Polymerase I requires the upstream
binding factor (UBF) and the promoter selectivity factor (SL1) for accurate initiation of
transcription from the human ribosomal promoter (Learned et al. 1985; Learned et al. 1986;
Bell et al. 1990).  UBF binds in a sequence specific manner to both core and the UCE.  In
contrast, SL1 has no or little affinity for the rRNA promoter but binds cooperatively with
UBF. SL1 consists of the TBP and three associated subunits, TAFI 110, TAFI 63 and TAFI
48 (Comai et al. 1992; Comai et al. 1994; Zomerdijk et al. 1994).  TAFI 48 serves as a
target for interaction with UBF and is required to form a transcriptionally active SL1
complex responsive to UBF in vitro (Beckmann et al. 1995).  TAFI 48 also alters the
ability of TBP to interact with TATA box elements, and the resulting complex fails to
support transcription by RNA Polymerase II (Beckmann et al. 1995).
Transcription of ribosomal RNA genes by RNA polymerase I oscillates during the
cell cycle, being maximal in S and G2 phases, repressed during mitosis, and gradually
recovering during G1 progression.  Silencing of cellular pre-rRNA synthesis during mitosis
is caused by the inactivation of the Pol I-specific transcription initiation factor SL1 by
12
cdc2/cyclin B-mediated phosphorylation of TAFI 110 (Heix et al. 1998).  Binding of SL1
to the core element of the ribosomal gene promoter is enhanced by the upstream binding
factor (UBF), a member of the family of high mobility group (HMG) box proteins (Jantzen
et al. 1990).  Interestingly the chromatin associated high mobility group (HMG) proteins 1
and 2 have been shown to stimulate DNA-PK activity in vitro (Watanabe et al. 1994).
Mitotic phosphorylation has been demonstrated to impair the capability of SL1 to
interact with UBF (Heix et al. 1998), indicating that phosphorylation of the Pol I-specific
TBP-TAF complex is used as a molecular switch to prevent pre-initiation complex
formation and rDNA transcription at mitosis.
DNA-PK was also found to be capable of repressing transcription by RNA
Polymerase I in vitro (Kuhn et al. 1995; Labhart 1995).  Transcriptional repression by
DNA-PK is due to protein phosphorylation. DNA-PK inhibits transcription from both
linear and circular templates, but the repression is more efficient on linear templates (Kuhn
et al. 1995; Labhart 1995).  Partial fractionation of the in vitro transcription system showed
that a protein fraction containing transcription factor Rib1, the Xenopus equivalent of
human SL1, mediated the repression of transcription by DNA-PK (Labhart 1995).
The effect of DNA-PK on Pol II and III has not been demonstrated so far.
Moreover, the precise molecular mechanisms of Pol I repression by DNA-PK or whether
DNA-PK is also capable of repressing Pol I transcription in vivo is not yet known.
3.  DNA-PK AND THE NUCLEAR MATRIX
As summarised above, a wide range of functions have been proposed for DNA-PK
many of which lack solid evidence.  To date, although its involvement in DNA DSB repair
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is well established, the molecular mechanisms that DNA-PK use while performing these
functions are not yet clear.  It is noteworthy to mention that DNA-PK is present at ~1x105
to 5x105 molecules per human cell (up to 1% of HeLa cell nuclear protein), which is far in
excess of the number of DNA DSBs generated by physiological doses of DNA damaging
agents and its levels do not appear to be regulated strongly by DNA-damaging agents (Lee
et al. 1997).  This could be because of the need for an immediate response to DNA damage
and by having huge amounts of DNA-PK, the damaged ends could be detected
immediately without spending time for the new protein synthesis.  However, the DNA is
not naked in the cellular environment and the chromatin context has to be considered when
proposing models for how DNA-PK binds to DNA and gets activated to perform its kinase
function.  It is possible that DNA-PK may need an accessory protein that would allow its
access to DNA wrapped in chromatin, which may prevent the exposition of broken DNA
ends.  Indeed, during DNA-PK purification from human cells, a substantial proportion (40
%) of DNA-PK was found to be associated with the insoluble fraction of the nucleus,
which constitutes the nuclear matrix (U. Yavuzer, unpublished data).
  Nuclear matrix by definition is the structure that can be isolated from cells after
removal of soluble proteins, histones and most of the DNA.  A group of proteins however,
stay tightly attached to DNA and cannot be removed even by treating with harsh
denaturants.  Accumulating evidence indicate the association of nuclear matrix with several
nuclear metabolic processes including DNA replication, transcription, RNA splicing,
topoisomerase activity, nucleotide excision repair, and DNA DSB repair (Berezney 1984;
Cockerill and Garrard 1986; Nelson et al. 1986; Verheijen et al. 1988; Jackson 1991;
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Kaufman and Shaper 1991; Yasui et al. 1991, 1994; Korte and Yasui 1993; Johnston and
Bryant 1994; Koehler and Hanawalt 1996).
Interestingly, attempts towards identifying the molecular mechanisms that DNA-PK
employ to perform its function revealed that a nuclear matrix protein C1D interacts
specifically with the putative leucine zipper region of DNA-PKcs.  This interaction is
interesting in the sense that C1D is capable of activating DNA-PK in the absence of free
DNA ends (Yavuzer et al. 1998). Moreover, the nuclear matrix protein C1D is
phosphorylated very efficiently by DNA-PK and its mRNA and protein levels have been
demonstrated to be induced upon γ-irradiation (Yavuzer et al. 1998), suggesting that C1D,
therefore the nuclear matrix may play a role in DNA DSB-response pathway in connection
with DNA-PK.   It is possible that C1D targets DNA-PK to the nuclear matrix and matrix-
associated DNA in response to DNA DSBs.  Indeed, the xrs-5 cells deficient in one of the
subunits of DNA-PK, Ku80, exhibit irregularly shaped nuclear envelope and altered
nuclear matrix compared to their wild-type controls (Korte and Yasui 1993, Yasui et al.
1991).
Recently, in this department, the yeast two-hybrid system was employed (Dincer et
al. unpublished) to identify the interacting proteins with C1D in order to reveal the
biological functions of the nuclear matrix and DNA-PK.  It was found that C1D interacts
with a group of proteins where TAFI 48 subunit of SL1 is one of them (unpublished data).
Given the connection between DNA-PK, Pol I and C1D, this interaction was thought to be
potentially interesting as verification of the interaction might shed light on to some of the
molecular mechanisms of how DNA-PK performs its function.
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The aim of this project therefore, is to demonstrate that C1D and TAFI 48 interact
in yeast, in mammalian cells and in vitro specifically with the hope that further
characterization of this interaction may provide clues about how transcription from rDNA
is regulated by DNA-PK in response to DNA damage.
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4.  MATERIALS AND METHODS
4.1.  BACTERIAL STRAINS
The bacterial strains used in this study were DH5α and M15.
Table 4.1: List of the E.coli strains used during the course of this study
 Strain Genotype Usage Source
M15
(pREP4)
F-, NalS, StrS, rif8, lac-, ara-, gal-,
mtl-, recA+, uvr+
Production of recombinant
proteins with pQE vectors
Villarejo and
Zabin 1974
DH5α F- supE44 hsdR17 recA1 gyrA96
endA1 thi-1 relA1 deoR lambda-
a recA- host for propagation and
storage of plasmids
Cold Spring
Harbour Labs.
4.2.  GROWTH AND MAINTENANCE OF BACTERIA
Bacterial strains were stored in 50% glycerol at –70oC for long-term storage.
Overnight grown cultures to saturation were mixed with sterile glycerol with a ratio of 1:1,
mixed to homogeneity, and stored at -70oC until required.  Bacteria was recovered by
scraping a small amount of cells from the frozen stock with an inoculation loop and
streaking onto a LB-agar plate (supplemented with the appropriate antibiotics).
Liquid culture of plasmid-carrying E.coli was performed in LB (5 g NaCl, 10 g
Bacto-tryptone, 5 g yeast extract, 1 ml of 1 M NaOH, ddH2O added to 1 L, sterilised by
autoclaving) with appropriate antibiotic selection.  Liquid cultures were constantly agitated
in a rotary shaking incubator (~200 rpm).  When supplementing LB-agar (LB medium with
1.5% agar) with antibiotic, the LB-agar was melted and allowed to cool to 55oC before the
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addition of antibiotic and pouring into 10 cm diameter plastic petri dish (Greiner
Labortechnik).  Plates were stored at 4oC and air-dried prior to use.
The specialised components of all media were obtained from Difco Laboratories
Ltd.
4.3. YEAST STRAINS
The yeast strain used in this study was L40.
Table 4.2: Features of the yeast strain L40
Strain Genotype Reporters Transformation
Markers
L40 MATa, his3∆200, trp1-901, leu2-3, 112,
ade2 LYS2::(lexAop)4-HIS,
URA3::( lexAop)8-lacZ GAL4
HIS3, lacZ Trp1, leu2
L40 is a reporter host used when screening fusion libraries for proteins that interact
with a target protein.  This strain carries both LacZ and HIS3 reporters integrated to URA3
and LYS2 genes of the yeast genome (Hollenberg et al. 1995).  The expression of the LacZ
and HIS3 coding sequences are driven, respectively by minimal GAL1 and HIS3 promoters
fused to multimerized LexA binding sites.
4.4.  GROWTH AND MAINTENANCE OF YEAST
Yeast strains were stored in 25% glycerol at –70oC for long-term storage.  Cultures
grown in the appropriate Yc selective medium (1.2 g yeast nitrogen base without amino
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acids, 5 g Ammonium sulfate, 10 g succinic acid, 6 g NaOH and 0.1 g of all the aminoacids
apart from his, ura, trp and leu were dissolved in 1 L, and autoclaved)  to saturation were
mixed with sterile glycerol with a ratio of 3:1, mixed to homogeneity, and stored at -70oC
until required.  Yeast cells were recovered by scraping a small amount of cells from the
frozen stock with an inoculation loop and streaking them onto a YPAD (or appropriate Yc)
agar plate.
Liquid cultures of yeast were performed in YPAD (10 g yeast extract, 20 g peptone,
0.1 g adenine, ddH2O added to 900 ml, sterilised by autoclaving, cooled to ~55oC and 100
ml of 20% filter-sterilised glucose added) or in the appropriate Yc medium.  Liquid
cultures were constantly agitated in a rotary shaking incubator (~200 rpm) at 30oC.
4.5.  MAMMALIAN CELLS
    The only mammalian cell line used in this study was COS-7 (ATCC CRL-1651).
This line was derived from the CV-1 cell line, African green monkey kidney origin,
(ATCC CCL-70) by transformation with an origin defective mutant of SV40 that codes for
wild-type T antigen.
4.6.  OLIGONUCLEOTIDES
Primers used in this study were synthesised in the Beckman Oligo 1000M DNA
Synthesiser (Beckman Instruments Inc. CA, USA) at Bilkent University, Department of
Molecular Biology and Genetics (Ankara, Turkey).
20
Cloning Primers:
1. UY 21 TAFI 48 Full Length Forward PCR Primer:
5′ AGACGTCGACAAGGATCC ATG AGT GAT TTC AGT GAA GAA 3′
2. UY 22 TAFI 48 Full Length Reverse PCR Primer:
5′ AGACCTCGAGTCTAGA TCA GAG TCT TGG ATT TAC AAT 3′
3. UY 54 TAFI 48 Full Length Reverse PCR Primer:
5′ AGACTCTAGACT GAG TCT TGG ATT TAC AAT ACT 3′
Table 4.3: Primer pairs used to amplify full-length open reading frame of TAFI 48
Primer Pairs PCR Product Size Annealing Temperature
UY21/UY22 1384 bp 61oC
UY21/UY54 1379 bp 58oC
4.7.  STANDARD SOLUTIONS AND BUFFERS
TBE Buffer:
Working Solution:                                          10x Stock Solution (1lt):
 45 mM Tris-borate                                         108 g Tris Base
   1 mM EDTA.                                                 55 g  Boric Acid
                                                                          40 ml 0.5 M EDTA, pH 8.0
TAE Buffer:
Working Solution                                           50x Stock Solution (1lt)
0.4 M Tris acetate                                           2 M Tris Base (242 g)
0.001 M EDTA                                               57.1 ml Glacial Acetic Acid
                                                                        50 mM EDTA
SalI
SalI
BamHI
BamHI
BamHI
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Phosphate-buffered saline (PBS):
Working Solution, ~pH 7.3:                            10x Stock Solution (1lt):
137 mM NaCl                                                  80 g NaCl
 2.7 mM KCl                           2 g KCl
 4.3 mM Na2HPO4.7H2O                                 11.5 g Na2HPO4.7H2O
 1.4 mM KH2PO4                                               2 g KH2PO4
4x Tris-Cl/SDS, pH 6.8:
Tris base 18.2 g, SDS 0.4g, ddH2O to 100 ml, adjusted to pH 8.8 with HCl.
4x Tris-Cl/SDS, pH 8.8:
Tris base 6.05 g, SDS 0.4 g, ddH2O to 100 ml, adjusted to pH 6.8 with HCl.
10x SDS-PAGE Running Buffer:
Tris base 30.2 g, Glycine 144g, ddH2O to 1L.
 Working Solution:
 100 ml 10x stock                        25 mM Tris
     5 ml  20% SDS                     192 mM Glycine
  895 ml ddH2O                          0.1% SDS
2x SDS PAGE Loading Buffer:
25 ml 4xTris-Cl/SDS pH 6.8
20 ml glycerol
3 g SDS
2 ml 2-ME
1 mg bromophenol blue
Add ddH20 to 100 ml
Transfer Buffer:
 Working Solution (for proteins less than 150 kD):
 25 mM Tris
 192 mM Glycine
 10% methanol
 Working Solution (for bigger proteins):
 50 mM Tris
 384 mM Glycine
 20% methanol
 0.1% SDS
1x TE:
10 mM Tris, pH 8.0
1 mM EDTA, pH 8.0
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4.8.  RECOMBINANT DNA TECHNIQUES
4.8.1.  Polymerase Chain Reaction
Polymerase chain reaction (PCR), a rapid procedure for in vitro enzymatic
amplification of a specific segment of DNA (Mullis and Faloona 1987), was performed to
amplify the coding sequence of TAFI 48.  PCR reactions were performed in 0.2 ml
ThermowellTM tubes (Corning Costar Corp.) using the GeneAmp PCR system 9600 (Perkin
Elmer).
PCR reactions were carried out in a reaction volume of 50 µl containing 1-2 ng of
template DNA, 5 µl 10x PCR buffer (Sigma), 5% DMSO (Sigma), 1.5 mM MgCl2
(Sigma), 0.2 mM of each dNTP (MBI Fermentas), 50 pmol of each primer and 1 unit Taq
DNA polymerase (Sigma).
The reaction was preheated to 94oC for 5 minutes and then subjected to 30 cycles of
denaturation (30 seconds at 95oC), annealing (1 minute at 61oC or 58oC depending on Tm
degrees of the primers), and elongation (90 seconds at 72oC).  At the end of the 30 cycles a
final extension at 72oC for 10 minutes was also applied.  PCR products were assessed by
agarose gel electrophoresis and EtBr staining.
4.8.2.  Phenol-chloroform extraction and ethanol precipitation of PCR products
This method was routinely used to purify and concentrate DNA preparations.  The
volume of the DNA solution was brought to 100 µl with ddH2O and an equal volume of
phenol was added on the solution to remove any protein contaminants.  The mixture was
vortexed vigorously and centrifuged at 13000 rpm for 2 minutes.  The upper aqueous layer
was removed, transferred into a new tube and an equal volume of chloroform was added to
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remove any residual phenol.  Once again the mixture was vortexed and centrifuged at
13000 rpm for 2 minutes.  The upper aqueous layer was removed and transferred into a
new tube.  To the estimated volume of the solution, 1/10 volume of 3 M NaAc pH 5.2, and
3 volumes of ice-cold absolute ethanol was added. The solution was then frozen at –70oC
for 10-30 minutes, followed by centrifugation at 13000 rpm for 20 minutes at 4oC. The
supernatant was removed and the pelleted DNA was washed with 70% ethanol to remove
salts and small organic molecules and dried at 37oC.  Finally, DNA was resuspended in
ddH2O at a concentration suitable for further experimentation and stored at –20oC.
4.8.3.  Purification of DNA fragments by Agarose Gel Electrophoresis
The samples were loaded into a single well of a 0.8%-1% low melting temperature
agarose gel containing 1µg/ml EtBr.  After electrophoresis, the DNA bands were visualised
under UV illumination and the desired bands were excised from the agarose gel with a
surgical blade (Aesculap Surgical Industries).  Agarose slices were suspended in about 300
µl of a buffer containing 10 mM Tris-HCl pH 8, 1 mM EDTA, and 100 mM NaCl.  The gel
slices were melted down by heating at 67oC for 20-30 minutes and while it was still at
67oC, an equal volume of phenol was added to the melted gel.  The mixture was vortexed
well and centrifuged for 15 minutes in a microfuge at 13000 rpm.
The melted gel material forms a thick precipitate at the interface.  The aqueous
phase was removed and was extracted once again with phenol, twice with an equal volume
of chloroform and optionally once with an equal volume of water-saturated ether.  Each
extraction was done by vortexing for a few seconds and between extractions, aqueous
phase was recovered by centrifugation in a microfuge for a few seconds at the maximum
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speed.  If used, residual ether after the last extraction was removed by heating the sample
for 3 min at 67oC.
The DNA was precipitated with 3 volumes of absolute ethanol for 30 min to
overnight at –70oC.  The DNA was pelleted by centrifugation at the maximum speed for 30
min at 4oC, followed by washing once with 0.5 ml of 70% ethanol.  The residual ethanol
was removed by drying the pellet at 37oC for 2 minutes.  The DNA pellet was resuspended
in appropriate volume of ddH2O.
4.8.4.  Restriction Enzyme Digestion of DNA
Depending on the amount of DNA (1-5 µg), restriction enzyme digests of DNA was
carried out in a total volume of 20-50 µl with 10-50 units of restriction enzyme, volume of
which was never greater than 1/10th of the total reaction volume.  Appropriate buffers and
incubation conditions were used for each digest as recommended by the manufacturer.
4.8.5.  DNA Ligation
DNA fragments were ligated into plasmid vectors as described in Molecular
Cloning (Maniatis et al. 1982).  Prior to ligation, vector and insert concentrations were
checked by agarose gel electrophoresis.  For undirectional cloning, vector: insert ratio was
set to 1:3 in molar terms and for directional cloning vector: insert ratio was kept close to 1
or slightly bigger than 1 in the ligation reactions.  Ligations were performed in 15 µl
reaction volumes containing 0.1-0.2 µg of plasmid DNA and the corresponding amount of
insert in the presence of 4 Weiss units of T4 DNA ligase, 1mM ATP and standard ligation
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buffer supplied by the manufacturer.  The reaction was kept at room temperature for 4
hours or at 16oC overnight.
4.8.6.  Plasmids
The plasmids used in this study to clone the full-length open reading frame of TAFI
48 are: pACT2, pQE30, T7-myc-pLink, pCMV 5’2N3T, pcDNA3.1/Myc-HisB and
pBlueBacHis2.  The available maps are presented  in figures 4.1, 4.2, 4.3 and 4.4.
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Figure 4.1: Restriction Map and Multiple Cloning Site (MCS) of pACT2
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Figure 4.2: Map of pQE30 vector and its MCS
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Figure 4.3: Map of  pcDNA3.1/Myc-His vectors
Figure 4.4: Map of pBlueBacHis2
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4.8.7.  Recombinant Expression Constructs
Constructs required for yeast, bacterial, mammalian and baculovirus expression, in
vitro transcription and translation were prepared as follows.  Inserts and plasmids were
digested with appropriate restriction enzymes, were run on agarose gel for concentration
determination and were ligated as described in the relevant section.  Half of the ligation
product was transformed into bacteria and recombinant plasmids were isolated (see
sections 4.9. and 4.10.).
Table 4.3: List of the constructs prepared during the course of this study
Vector Digest Insert Digest Construct Usage
pACT2 (XhoI) UY21/22 (PCR pr.)
(SalI/XhoI)
TAFI 48-pACT2 Yeast expression
pQE30 (BamHI/SalI) TAFI 48-pACT2
(BamHI/XhoI)
TAFI 48-pQE30 Bacterial protein
expression and
purification
T7-myc-pLink
(BamHI/XhoI)
TAFI 48-pACT2
(BamHI/XhoI)
TAFI 48-T7-myc-
pLink
in vitro
transcription and
translation
pCMV 5’2N3T (SalI) UY21/22 (PCR pr.)
(SalI/XhoI)
TAFI 48-pCMV Mammalian
expression
pcDNA3.1/Myc-HisB
(BamHI/XbaI)
UY21/54 (PCR pr)
(BamHI/XbaI)
TAFI 48-
pcDNA3.1
Mammalian
expression
pBlueBacHis2
(BglII/SalI)
TAFI 48-T7-myc-
pLink
(BamHI/XhoI
TAFI 48-
pBlueBacHis2
Baculovirus
expression
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4.9.  PREPARATION OF COMPETENT CELLS AND TRANSFORMATION OF
E.COLI
4.9.1.  CaCl2 Method
            A single colony of an appropriate E.Coli strain was inoculated in 5 ml of LB
(containing the appropriate antibiotics) and grown overnight at 37oC.  The starter culture
was diluted to an O.D600 of 0.2-0.3 in 50 ml of LB (containing the appropriate antibiotics)
and was grown further until the O.D600 reached to 0.6-0.7.  The culture was cooled on ice
for 10 minutes and the cells were pelleted by centrifugation at 4000 rpm for 10 minutes at
4oC.  The pellet was resuspended in 40 ml of ice cold filter-sterilised 100 mM CaCl2 and
incubated on ice for 1 hour.  The cells were then pelleted as above and resuspended in 2 ml
of ice cold sterile 100 mM CaCl2.  The competent cells prepared by this way can be kept on
ice till transformation up to 24 hours (Cohen et al. 1972)
4.9.2.  Simple and Efficient Method (SEM)
            A single colony of appropriate E.coli strain was inoculated into 15 ml of LB
(containing the appropriate antibiotics) and grown overnight at 37oC.  The starter culture
was diluted to an O.D600 of 0.2-0.3 in 250 ml of SOB medium (2% Bacto-tryptone, 0.5%
yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, sterilised by
autoclaving) and grown to an OD600 of 0.6 at 18oC with shaking at 200-250 rpm.  The
culture was chilled on ice for 10 minutes, centrifuged at 2500 g for 10 minutes at 4oC.  The
pellet was then resuspended in 80 ml of ice-cold TB (10 mM Pipes, 55 mM MnCl2, 15 mM
CaCl2, 250 mM KCl, pH 6.7, sterilised by filtration through 0.45 µm filter, stored at 4oC),
and incubated on ice for 10 minutes.  The mixture was pelleted as above, resuspended
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gently in 20 ml of TB.  DMSO was added to a final concentration of 7%, mixed gently and
incubated on ice for 10 minutes.  Aliquots of this mixture were then immediately chilled in
liquid nitrogen, and stored at –70oC up to 3 months without loss of transformation
efficiency (Inoue et al. 1990).
4.9.3.  Transformation of E.Coli
For transformation using competent cells prepared by CaCl2 method, DNA (less
than 100 ng) was added to 200 µl of competent cells in a microfuge tube, and incubated on
ice for 30 minutes.  The cells were then exposed to a 90 seconds heat shock at 42oC, chilled
on ice for 1-2 minutes, and 800 µl of LB was added and followed by incubation at 37oC for
one hour.  The culture was then pelleted, resuspended in 100 µl of LB, and was spread on
LB-agar plates supplemented with appropriate antibiotics (50 µg/ml ampicillin and/or 25
µg/ml kanamaycin).  The plates were left for drying, then inverted and incubated overnight
at 37oC (Cohen et al. 1972).
For transformation with supercompetent cells, an aliquot of frozen competent cells
was thawed on ice. 200 µl of the cells was mixed with plasmid DNA (less than 100 ng) in a
15 ml round bottom tube (Greiner Labortechnik), and incubated on ice for 30 minutes.  The
cells were then exposed to a 30 seconds heat shock at 42oC, chilled on ice for 1-2 minutes,
800 µl of SOC (SOB with 20 mM glucose) was added and the cells were grown at 37oC for
one hour with vigorous shaking at 250 rpm.  The culture was then pelleted, resuspended in
100 µl of SOC, and was spread on LB-agar plates as described above (Inoue et al. 1990).
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4.10.  PLASMID DNA ISOLATION
4.10.1.  Small Scale Plasmid Isolation
Small-scale preparation of plasmid DNA was performed by standard methods based
on NaOH/SDS cell lysis and potassium acetate precipitation of cellular debris (Maniatis et
al. 1982).
Cells were harvested by centrifugation (13,000 rpm, 3 minutes, at room
temperature) from a 1.5 ml overnight culture of bacteria carrying the plasmid of interest.
Following resuspension of the bacterial pellet in 100 µl of solution I (50 mM glucose, 25
mM Tris-Cl pH 8.0, 10 mM EDTA), 200 µl of freshly prepared solution II (200 mM
NaOH, 1% SDS) was added and cells were lysed by gently inverting the tube a few times.
Bacterial chromosomal DNA and proteins were precipitated by the addition of 150 µl of
solution III (3 M potassium acetate, 11.5% glacial acetic acid).  An equal volume of
phenol: chloroform (1:1) mixture was added and the mixture was vortexed well.  The
phases were separated by centrifugation at 13,000 rpm for 5 minutes at room temperature
and upper aqueous layer was transferred into a new tube.  The DNA was precipitated from
the aqueous phase by addition of 1 ml of cold absolute ethanol and the DNA was pelleted
by centrifugation at 13000 rpm for 20 minutes at 4oC.  After washing once with 70%
ethanol, the pellet was dried and resuspended in 30 µl of ddH2O with 10 µg/ml DNase-free
RNase A (Roche Molecular Biochemicals) to remove any RNA contaminant.
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4.10.2.  Medium Scale Isolation (Midi-Preparation)
Cells were grown in 50-100 ml of LB (containing the appropriate antibiotic)
overnight to saturation and plasmid DNA was isolated by using Nucleobond AX 100
(Macherey-Nagel), according to the manufacturer’s instructions.
4.10.3.  Spectrophotometric Quantification of DNA
The amount and the purity of DNA samples were determined by reading the
absorbance of samples at 260 nm and 280 nm in a spectrophotometer (Beckman
Instruments Inc., CA; USA).  Nucleic acid samples displaying OD260 /OD280 ratio in the
range of 1.8 to 2.0 are regarded as highly pure.  A value of OD260=1.0 corresponds to a
concentration of approximately 50 µg/µl for double stranded DNA, 40 µg/ml for single
stranded DNA and 20 µg/µl for oligonucleotides (Maniatis et al. 1982).
4.11.  YEAST TECHNIQUES
4.11.1.  Small Scale Yeast Transformation
A single colony of L40 was inoculated in 10 ml of YPAD and grown overnight at
30oC with shaking at 200 rpm.  The starter culture was diluted to an O.D600  of 0.2-0.3 in
50 ml of YPAD medium and was grown further until the OD600 reached to 0.6-0.7.  All
subsequent steps were carried at room temperature.  Yeast cells were pelleted at 2500 rpm
for 10 minutes.  After resuspending the pellet in 40 ml 1x TE, cells were repelleted and
resuspended in 2 ml of  LiAc/TE (100 mM LiAc in 0.5x TE), and incubated at room
temperature for 10 minutes.  Meanwhile 0.1 µg of DNA was dissolved in 8 µl of ddH2O
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and 10 µl of salmon sperm DNA was added.  175 µl of competent yeast cells was
dispensed to DNA tubes, mixed by flicking.  700 µl of 100mM LiAc/ 40% PEG-3350/1x
TE was added and incubated at 30oC for 30 minutes on a rotating wheel.  Subsequently, 88
µl of DMSO was added, followed by a heat shock at 42oC for 7 minutes.  Cells were then
pelleted at full speed for 10 seconds, supernatant aspirated, and the pellet was resuspended
in 1.0 ml of  1x TE.  Cells were pelleted once more as above, resuspended in 100 µl of 1x
TE, and were plated on the appropriate selective medium (Ito et al. 1983, Gietz et al. 1992).
4.11.2.  Liquid Culture Assay Using ONPG as Substrate
 Liquid yeast cultures were assayed for β-galactosidase activity to verify and
quantify the interaction between two proteins of interest.  L40 cells were cotransformed
with the plasmid expressing TAFI 48 in fusion with the activation domain of GAL4 (TAFI
48-pACT2)  and each of the different baits expressing Lamin, Daughterless and C1D in
fusion with a DNA binding domain (LexA DNA-binding domain (DBD) alone, DBD-
Lamin, DBD-Daughterless, or DBD-C1D). 3 colonies were picked from each
transformation plate and were grown in 4 ml of the appropriate selective liquid medium for
2 days. 2 ml of the saturated culture was transferred into 8 ml of YPAD.  The cultures were
incubated at 30oC for 3-5 hrs with shaking (230-250 rpm) until the cells grew to the mid-
log phase (O.D600 = 0.5-0.8).  The exact value of O.D600 was recorded when harvesting the
cells.  1.5 ml of culture was placed into each of three 1.5-ml microcentrifuge tubes.  Cells
were collected by centrifugation at 13000 rpm for 30 sec.  After the supernatants were
removed, the cells were resuspended in 1.5 ml of Z-buffer (60 mM Na2HPO4, 40 mM
NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7).  Cells were centrifuged again and
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supernatants were removed.  Each pellet was resuspended in 300 µl of Z buffer so that the
concentration factor was 5 fold. 0.1 ml of the cell suspension was transferred into a fresh
microcentrifuge tube.  Cells were lysed by freezing in liquid nitrogen for 30 seconds,
followed by thawing in a 37oC water bath.  The freeze/thaw cycle was repeated for two
more times to ensure that the cells had broken open.  A blank tube with 100 µl of Z buffer
was set up.  0.7 ml of Z buffer (+ β-mercaptoethanol) was added to the reaction and blank
tubes.  The tubes were placed in a 30oC heat block. 160 µl of 4 mg/ml ONPG (Sigma)
(prepared in Z buffer) was added to the reaction and blank tubes and the elapsed time until
the yellow colour developed was recorded.  When the colour developed, 0.4 ml of 1M
Na2CO3 was added to the tubes to stop the reaction.  The reaction tubes were centrifuged
for 10 minutes at 13000 rpm to pellet the cell debris and the supernatants were transferred
into clean cuvettes.  The spectrophotometer was calibrated against the blank tube at A420
and the O.D420 of the samples relative to the blank were measured.  Finally, β-galactosidase
units was calculated according to the following formula:
β-Galactosidase units =1000 x OD420 /(t xVx OD600)
Where:                       t = elapsed time (in min) of incubation
                           V = 0.1 ml x concentration factor
1 unit of β-galactosidase is defined as the amount that hydrolyzes 1 µmol of ONPG to o-
nitrophenol and D-galactose per min per cell (Miller 1972).
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4.12.  CELL CULTURE TECHNIQUES
4.12.1.  Thawing a Frozen Cell Line
Frozen cell line stock in cryotube was transferred from liquid nitrogen into ice and
then the frozen cells were thawed at 37oC in less than 2 minutes.  After thawing, cells were
transferred into a 15 ml falcon tube and 10 ml of warmed fresh culture medium (DMEM
supplemented with 10% FCS and 1% Penicillin/Streptomycin, all purchased from
Biochrom) was added dropwise.  Cells were collected by centrifugation at 1500 rpm for 5
minutes at 4oC and the medium was removed by aspiration without disturbing the cell
pellet.  The pellet was then resuspended in 5 ml of fresh culture media and transferred into
a 25 cm2 culture flask (Greiner Labortechnik).  The culture flask was incubated at 37oC in a
humidified atmosphere with 5% CO2 for cell growth (Doyle and Griffiths 1997).
4.12.2.  Sub-Culturing of Monolayer Cells
When reached to 80% confluence, cells were sub-cultured into new flasks.  The
medium was aspirated and monolayer cells were rinsed quickly with a volume of 0.25%
trypsin/0.03% EDTA solution (Biochrom) just enough to cover the surface.  The solution
was removed and an additional amount of trypsin-EDTA solution was added.  After
incubation at 37oC for 30 seconds, the trysin-EDTA solution was removed and the flask
was allowed to sit at 37oC until the cells detached.  2-10 ml (depending on the size of the
culture flask) of culture media was added and any cell remaining attached was suspended
by gently pipetting.  The medium was transferred to a fresh 15 ml falcon tube.  Following
centrifugation at 1500 rpm for 5 minutes at 4oC, the medium was removed by aspiration
without disturbing the cell pellet.  Then the pellet was resuspended in 5 ml of fresh culture
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media and was dispensed into new culture flasks at the desired sub-culturing ratio.
Additional fresh culture medium was added and the flasks were incubated at 37oC in a
humidified atmosphere with 5% CO2 (Doyle and Griffiths 1997).
4.12.3.  Cryopreservation
As in sub-culturing the cells were collected but instead of the culture medium, cells
were resuspended in adequate amount of freezing medium (DMEM supplemented with 5%
FCS and 10% DMSO) to give a cell density of 5 x 106 cells /ml, dispensed into cryotubes
and were frozen overnight at –80oC from where transferred into liquid nitrogen (Doyle and
Griffiths 1997).
4.12.4.  Transient Transfections
All transfections were performed with the FuGENE6 (Roche Molecular
Biochemicals) transfection reagent according to the manufacturer’s instructions.  One-day
before transfection, 2 x 105 cells in 4 ml total media were plated into a 60 mm culture dish
(Greiner Labortechnik).  On the day of transfection, cells should be 50-80% confluent and
most cell lines plated at a density of 2 x 105 cells/ 4 ml in 60 mm culture dishes will
achieve this confluency after overnight incubation at 37oC with 5% CO2.
4.13.  GEL ELECTROPHORESIS
4.13.1.  Agarose Gel Electrophoresis
DNA fragments were separated by gel electrophoresis using agarose at
concentrations of 0.8-2.0% w/v in 1x TBE buffer.  Samples were mixed with a fifth volume
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of loading dye (8% deionised formamide, 1x TBE and 0.1% bromophenol blue) and the
samples were loaded onto the gel.  Electrophoresis was performed by running the gel at
100V.  At the mid of the run, the gel was soaked briefly in 1x TBE containing 0.1% EtBr,
and then was run further to completion.  Gels were visualised by illuminating with UV
light on a transilluminator at 302nm.  The gel photos were captured with BioRad Multi-
Analyst Software running on a PC and a hardcopy was produced by Lexmark Optra laser
printer.
4.13.2.  SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Electrophoretic separation of proteins under denaturing conditions was performed
by following the methods described in Current Protocols (Ausubel 1987). Resolving gels
were made up to the required concentration, 10-15%, from a 40% acrylamide stock
solution (38% acrylamide, 2% bisacrylamide, Severn laboratories).  The electrophoresis
apparatus (Mini-Protean 3, BioRad) was assembled according to manufacturer’s
instructions.  Acrylamide stock solution (to the desired gel percentage) and 4x Tris-Cl/SDS
pH 8.8 were mixed in ddH2O and 10% ammonium persulphate and TEMED (30 µl and 10
µl, respectively for a 5 ml solution) were added to assist polymerisation.  The mixture was
then poured into the gap between the glass plates so that sufficient space is left for the
stacking gel and water saturated isobutanol was layered immediately onto the top of the
gel.  After the polymerisation, the isobutanol layer was removed, washed with water and
the stacking gel (0.49 ml of acrylamide stock solution, 3.225 ml ddH2O, 1.25 ml 4x Tris-
Cl/SDS pH 6.8, 30µl of 10% ammonium persulphate, 5 µl of TEMED) was poured onto
the top of the resolving gel.  The comb was immediately inserted into the stacking gel
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avoiding the formation of bubbles.  After the stacking gel polymerised, the comb was
carefully removed and the wells were rinsed with the running buffer to remove any
unpolymerised acrylamide.  The samples were mixed with appropriate volume of 2x SDS
loading buffer, boiled at 100oC for 5 minutes to denature proteins, centrifuged at full speed
for 5 minutes, and then loaded on to gel.  Gels were run at 70V until the samples left the
stacking gel.  As the samples passed to the resolving gel the voltage was raised to 100V.
After the electrophoresis, to detect the proteins, gel was carefully removed and stained in
Coomassie Brilliant Blue (0.25% Coomassie Brilliant Blue G250, 45% methanol, 10%
acetic acid) for 20 minutes, and destained in a solution of 30% methanol, 10% acetic acid,
and 60% deionised distilled water for 1-4 hours.  Alternatively gels were subjected to
electrophoresis for the purpose of immunoblotting.
4.14.  BIOCHEMICAL TECHNIQUES
4.14.1.  Immunological Detection of Immobilized Proteins (Western Blotting)
4.14.1.1  Transfer of Proteins onto Membranes
Following SDS-PAGE, proteins were transferred from the gel to a nitrocellulose
membrane (Schleicher & Schuell) using Mini Trans- Blot Cell (BioRad).  Two sheets of 3
MM Whatman paper (Whatman International Ltd.) and one sheet of nitrocellulose
membrane were cut to the dimensions of the gel to prepare the transfer stack.
Nitrocellulose membrane was wetted in ddH2O by capillary action.  The gel, the
membrane, Whatman papers and fiber pads were soaked in transfer buffer (25 mM Tris,
192 mM Glycine, 10% methanol or 50 mM Tris, 384 mM Glycine, 20% methanol and
0.1% SDS) for 15 minutes.  Then the transfer stack was assembled in the following order
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starting from the side that would face the cathode: fiber pad, one sheet of Whatman paper,
the gel, the nitrocellulose membrane, one sheet of Whatman paper and finally the second
fiber pad.  While preparing the transfer stack, formation of any air bubbles between the
layers was avoided.  The transfer stack was then placed into the tank filled with transfer
buffer and transfer was performed at 100V for 1 hour for proteins with molecular weights
smaller than 150 kD and at 40V for 2 hours for bigger proteins.
4.14.1.2.  Immunological Detection of Immobilized Proteins
After the transfer has been completed, the membrane was washed twice with TBS-
T (TBS + 0.5% Tween-20), and incubated in 50 ml of blocking solution (10% non-fat dry
milk in TBS-T) with continuous shaking for two hours at room temperature or overnight at
4oC.  After blocking, the membrane was washed four times for 10 minutes each with TBS-
T.  The membrane was then incubated with the solution containing the primary antibody
(diluted in 1% non-fat dry milk in TBS-T) for 1 hour.  The membrane treated with the
primary antibody was washed four times for 10 minutes each with TBS-T.  The membrane
was then treated with the HRP (horse reddish peroxidase) conjugated secondary antibody
(diluted in 1% non-fat dry milk in TBS-T) for 1 hour and was washed as described before.
The immunodetection with HRP conjugated secondary antibody was carried out by
using Amersham LIFE SCIENCE ECL Western blotting detection reagents according to
the manufacturer’s instructions.  The bands were visualised by exposing the membrane on
photograph films.
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4.14.1.3.  Striping and Reprobing Membranes
This method was used to remove the primary and secondary antibodies completely
from membranes. The membrane was submerged in stripping buffer (100 mM 2-
mercaptoethanol, 2% SDS, 62.5 mM Tris-Cl pH 6.7) and the membrane was incubated at
65oC for 30 minutes with occasional agitation.  The membrane was then washed four times
for 10 minutes with large volumes of TBS-T at room temperature and all steps described
above were applied for the immunodetection.
4.14.1.4.  Peptide Neutralisation of Primary Antibody
For peptide neutralisation, primary antibody was combined with a five-fold (by
weight) excess of blocking peptide in a small amount of PBS.  The mixture was incubated
for 2 hours at room temperature.  Following neutralisation, antibody/peptide mixture was
diluted in 1% non-fat dry milk in TBS-T and the protocol for immunological detection was
performed as described above.
4.14.2.  Immunoprecipitation
After thirty hours following transfection, the medium was aspirated and monolayer
cells were rinsed twice with PBS at room temperature.  All the following steps were carried
out at 4oC using ice-cold buffers. 1.5 ml of PBS + 50 mM EDTA was added on monolayer
cells and cells were incubated on a shaker for 10 minutes.  After incubation, cells were
scraped with a rubber scraper and were transferred into a microcentrifuge tube . Cells were
collected by centrifugation at 2000 rpm for 5 minutes.  The supernatant was removed; cells
were resuspended in 0.1 ml of Lysis buffer (150 mM NaCl, 1 mM EDTA, 20 mM Tris pH
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8.0, 0.5% NP-40, 10% glycerol, 1x CompleteTM protease inhibitors) and were incubated on
a rotating wheel for 30 minutes.  Following incubation cell lysates were spun down at
10,000g for 10 minutes to remove the insoluble cell debris.  The supernatant, which is the
total cell lysate, was removed into a new tube and was incubated with the appropriate
antibody for 2 hours on a rotating wheel.  Meanwhile 20 µl of resuspended volume of the
appropriate agarose conjugate (10 µl of Protein A-agarose + 10 µl of Protein G-agarose)
was washed three times with 0.5 ml of Lysis Buffer (10 minutes washing followed by 5
minutes centrifugation at 2500 rpm to remove supernatant).  After 2 hours incubation, cell
lysate/antibody mix was added onto equilibrated beads and was incubated for further 2
hours.  The beads were collected at the end of the incubation by centrifugation at 2500 rpm
for 5 minutes and the supernatant was removed.  Then the beads were washed four times
with 0.5 ml of Lysis buffer as described before.  After the last wash, supernatant was
discarded and the beads were resuspended in 20 µl of 2x SDS Loading Buffer.  The
samples were boiled for 5 minutes, centrifuged at full speed for 5 minutes and then loaded
on to SDS PAGE gel.  After electrophoresis, proteins were transferred to a nitrocellulose
membrane and the immunological detection of the immobilized proteins was performed.
4.14.3.  Protein Purification of Glutathione-S-Transferase Tagged C1D Protein
The pGEX vectors are designed so that foreign polypeptides can be expressed in
E.coli in a form that allows them to be purified rapidly under nondenaturing conditions.
Foreign polypeptides are expressed as fusions to the C terminus of glutathione-S-
transferase (GST), a common 26 kD cytoplasmic protein of eukaryotes.  The fusion protein
typically remain soluble within the bacteria and can be purified from lysed cells because of
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the affinity of the GST moiety for glutathione immobilised on agarose or sepharose beads.
Recovery of the fusion protein is by elution with free reduced glutathione at reduced pH
(Ausubel 1987).
            A single colony of M15 strain of E.Coli transformed with pGEXTK2-C1D
construct was inoculated in 5 ml of LB (supplemented by 50 µl/mg ampicillin and 25 µl/mg
kanamaycin) and grown overnight at 37oC.  The starter culture was diluted to an O.D600 of
0.2 in 50 ml of LB (containing the appropriate antibiotics) and was grown at 30oC till its
O.D600 reached to 0.55.  IPTG (MBI Fermentas) was added to a final concentration of 0.15
mM and cells were grown further for 3 hours at 30oC.  Cells were then harvested at 4000
rpm for 20 minutes at 4oC, and then resuspended in 1 ml TBS-PMSF (1% Triton, 1mM
PMSF, BSA 10 µg/ml, 1x CompleteTM protease inhibitors diluted in TBS).  Cells were then
sonicated on ice giving 10 seconds bursts at 300 W by the aid of UP 50 Ultrasonic
Processor (UniEquip), and were centrifuged at 8000 rpm for 30 minutes at 4oC.
Meanwhile, 30 µl of glutathione-sepharose-4B beads (Pharmacia Biotech) were
equilibrated by washing with 0.5 ml of 50% TBS at 4oC (10 minutes incubation, 5 minutes
centrifugation at 2500 rpm 4oC to remove supernatant) four times.  The supernatant from
the cell lysate was then loaded onto the equilibrated beads and rotated at 4oC for 30
minutes.  Supernatant was then removed at the end of binding step and was preserved for
checking.  The beads were then washed with 0.5ml of TBS-PMSF four times as described
before.  Finally the beads were suspended in 50µl of TBS-PMSF and 8 µl of glycerol was
added for storage at -20oC. 10 µl of beads with slurry was mixed with appropriate volume
of 2x SDS-PAGE loading dye.  Samples were boiled at 100oC for 5 minutes, centrifuged at
full speed for 5 minutes and analysed on SDS-PAGE.
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4.14.4.  Protein Purification by Immobilised Metal Ion Affinity Chromatography
Proteins expressed by using the QIAexpress (Qiagen) pQE expression vector
system carry a stretch of six consecutive histidine residues (His-tag) fused to their amino
terminal region allowing affinity purification using nickel ions immobilised on a metal
chelation resin.  Elution of the bound protein is performed by imidazole or by lowering the
pH.  Purification could be carried out under native conditions or, if the protein is insoluble,
under denaturing conditions.  The principals of the purification system and the basic
protocols used are described in the QIAgen QIAexpress Handbook (1992).
A single colony of M15 strain of E.Coli transformed with pQE-C1D construct was
inoculated in 10 ml of LB (supplemented by 50 µl/mg ampicillin and 25 µl/mg
kanamaycin) and grown overnight at 37oC.  The starter culture was diluted to an O.D600
around 0.2 in 100 ml of LB (with the appropriate antibiotics) and was grown at 37oC until
its O.D600 reached to 0.75.  IPTG was added to a final concentration of 0.5 mM and cells
were grown further for 4 hours at 37oC.  The cells were harvested by centrifugation at 4000
rpm for 20 minutes at 4oC; the pellet was then resuspended in Buffer B (8M urea, 0.1 M
NaH2PO4, 0.01 M Tris, pH adjusted to 8.0 using 10 M NaOH) at 5 ml Buffer B/gram
weight of pellet.  The cells were then stirred in a sterile beaker for one hour at room
temperature.  Meanwhile, 1.6.ml of a 50% slurry Ni-NTA resin (Qiagen) was loaded to a
column with a flow rate of 10-15 ml/hr and was equilibrated by washing 10 column
volumes of buffer B.  The lysate was centrifuged at 10,000g for 15 minutes at 4oC, and the
supernatant was collected and was loaded onto the column pre-equilibrated in Buffer B.
The column was then washed with Buffer B until the OD280 of the flow-through was lower
45
than 0.01, and with Buffer C (8M urea, 0.1 M NaH2PO4, 0.01 M Tris, pH adjusted to 6.3
using 37% HCl) until OD280 of the flow-through was lower than 0.01.
4.14.5.  Protein Refolding
Each denatured proteins needs to be refolded according to a specially optimised
protocol.  Refolding is generally carried out by gradual dilution of the denaturing agents,
together with careful reformation of the disulfide bridges.
Many proteins that are insoluble can be successfully refolded while immobilised on
the Ni-NTA column.  It may be that immobilising one end of the protein during
renaturation prevents the formation of misfolded aggregates.  The column containing the
His-C1D was applied to a linear 6 M- 0 M urea gradient in 500 mM NaCl, 20% Glycerol,
20 mM Tris-Cl pH 7.4 over a period of 12 hours.  The refolded C1D was kept immobilized
on the Ni-NTA beads in 0.1x TE (containing protease inhibitors) for the Ni-NTA pull-
down assays.  Alternatively to use in the kinase assays, the folded C1D was eluted with the
addition of 250 mM imidazole in 0.1X TE (containing protease inhibitors) and collected
fractions were analysed by SDS PAGE.  Fractions containing the recombinant protein were
further analysed by western blotting to confirm the protein purification.  Eluted proteins
were kept in the same buffer at 4oC till usage.
4.14.6.  In vitro Transcription and Translation
The in vitro transcription and translation of target proteins were carried out using
the TNT T7 Coupled Reticulocyte Lysate System (Promega), according to the
manufacturer’s instructions using [35S]-methionine.  Samples (5µl) of the [35S]-methionine-
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labelled translation products were electrophoretically separated on a SDS-Polyacrylamide
gel and the bands were visualised by autoradiography.
4.14.7.  Pull-Down Assays
4.14.7.1.  Ni-NTA Pull-Down Assay
Before the binding reaction, Ni-NTA bound to the protein of interest was
equilibrated by washing (10 minutes incubation followed by centrifugation at 2500 rpm for
5 minutes and disposal of the supernatant) three times with binding buffer (20% glycerol,
100 mM NaCl, 0.1x TE pH 8.0, 0.1% NP-40, 1x Complete protease inhibitors).  20 µl of
radiolabelled translation product and Ni-NTA bound to the protein of interest were
incubated in 200 µl of Binding buffer containing 1mM DTT and 30 µg BSA for one hour at
room temperature on a rotating wheel.  At the end of the incubation the beads were
collected by centrifugation at 2500 rpm for 5 minutes and the supernatant was removed.
Then the beads were washed four times with 1 ml of wash buffer (20% glycerol, 100 mM
NaCl, 0.1xTE pH 8.0, 0.3% NP40, 1x complete protease inhibitors) at 4oC as described
before.  After the last wash the supernatant was discarded and the beads were resuspended
in 20 µl of 2x SDS-PAGE loading buffer, boiled, centrifuged at 13000 rpm for 5 minutes
and loaded on 10% SDS-PAGE.  After electrophoresis, the gel was soaked in fixing
solution (50% methanol, 10% glacial acetic acid, 40% ddH2O) for 30 minutes.  After
pouring off the fixing solution, for increased detection sensitivity the gel was soaked in
Amplify Reagent (Amersham) for 30 minutes and finally soaked in 7% acetic acid, 7%
methanol, 1% glycerol for 5 minutes to prevent the gel from cracking during drying.  The
gel was placed on a sheet of Whatman 3MM filter paper, covered with plastic wrap and
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dried at 65oC for 2 hours under a vacuum using a conventional gel drier (Savant).  After
drying, the gel was exposed to the film.
Alternatively Ni-NTA pull-downs were performed in the following binding buffers:
Buffer A (100 mM NaCl, 20% glycerol, 20 mM Tris-Cl pH 7.5, 0.3% NP40, 1x complete
protease inhibitors), Buffer B (50 mM NaPhosphate pH 8.0, 100 mM NaCl, 12.5 mM
MgCl2, 0.3% NP40, 1x complete protease inhibitors) or Buffer C (25 mM HEPES pH 7.6,
0.1 mM EDTA, 12.5 mM MgCl2, 20% glycerol, 0.3% NP40, 100 mM KCl, 1x complete
protease inhibitors).
4.14.7.2.  GST Pull-Down Assay Using Immobilized GST-C1D
 Before the binding reaction, glutathione sepharose-beads bound to GST and GST-
C1D were equilibrated by washing three times with Z buffer (25 mM HEPES pH 7.5, 12.5
mM MgCl2, 20% Glycerol, 0.1% NP-40, 150 mM KCl, 1x complete protease inhibitors) as
described before.  20 µl of glutathione sepharose beads bound to the protein of interest was
preincubated in 200 µl of Z buffer containing 1 mM DTT and 30 µg BSA with gentle
rocking for 10 minutes at room temperature.  Then, 20 µl of radiolabelled translation
product was added onto the beads, and incubated at room temperature for 1 hour with
gentle rocking.  At the end of incubation, samples were centrifuged at 2500 rpm for 5
minutes and the supernatant was removed.  The beads were then washed four times with 1
ml of NETN (20 mM Tris-Cl pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% NP40, 1x
complete protease inhibitor) at 4oC.  Samples were then analysed on SDS-PAGE and the
gel was dried and exposed to film as described in the previous section.
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Alternatively GST pull-down assay was performed through another route.  Instead
of using radiolabelled translation product, lysate of COS7 cells transiently transfected with
the plasmid expressing the protein of interest was incubated with the beads.  Cells were
collected as described in immunoprecipitation section and were resuspended in 50 µl of
Lysis Buffer (25 mM HEPES pH 7.5, 12.5 mM MgCl2, 20% Glycerol, 0.5% NP-40, 150
mM KCl, 1x complete protease inhibitors) and were incubated on a rotating wheel for 30
minutes.  Following incubation cell lysates were spun down at 10000g for 10 minutes to
remove the insoluble cell debris.  The supernatant, which is the total cell lysate, was
removed into a new tube and diluted to 250µl with the dilution buffer (25 mM HEPES pH
7.5, 12.5 mM MgCl2, 20% Glycerol, 150 mM KCl, 1x complete protease inhibitors).  The
cell lysate was then added onto the glutathione sepharose beads bound to the protein of
interest and was incubated for 1 hour at room temperature on a rotating wheel.  Beads were
washed as before and were subjected to electrophoresis.  After electrophoresis, proteins
were transferred to a nitrocellulose membrane and the immunological detection of the
immobilized proteins was performed.
4.14.8.  Kinase Assays
Two nanograms of purified DNA-PKcs together with 5 ng of Ku was incubated
with 100 ng of purified His-C1D and 100 ng of linear DNA in the presence of 20 µl of Z’
buffer (25 mM HEPES pH 7.9, 50 mM KCl, 10 mM MgCl2, 20% glycerol, 0.1% NP40,
1mM DTT, and 200 µM ATP) for 10 minutes on ice and the reaction was started by adding
10 µCi of [γ32-ATP].  Following incubation at 30o C for 30 minutes, phosphorylated
proteins were subjected to 15% SDS-PAGE and visualised by autoradiography.
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When immuno-complex protein kinase assays were performed, immunoprecipitates
were prepared as described before and were washed three times with Z’ buffer without
ATP.  After the last wash, 10 µl of immunoprecipitates was added to the kinase reaction
mixture and kinase assay was performed as described before.
 4.15.  RADIOCHEMICALS
[35S]methionine and [γ-32P]ATP were   supplied by Amersham International and
DuPont NEN.
4.16.  RESTRICTION AND DNA MODIFYING ENZYMES
All enzymes were obtained from GibcoBRL, except Taq DNA polymerase and
related components from Sigma, and used according to the instructions of the
manufacturers.
4.17.  CHEMICALS, KITS AND SPECIAL CONSUMABLES
All chemicals were purchased from Sigma, Difco, Carlo-Erba, or Merck and plastic
disposables from Costar or Greiner Labortechnik. Plasmid purification kit was supplied by
Macherey-Nagel, Ni-NTA resin for histidine tagged protein purification by Qiagen, and
TNT coupled reticulocyte lysate kit by Promega. FuGene6 transfection reagent and
complete protease inhibitor cocktail were obtained from Roche Molecular Biochemicals.
IPTG was obtained from MBI Fermentas, ONPG from Sigma, ECL from Amersham  Life
Science, X-ray films from Kodak. Anti-HA and Anti-TAFI 48 antibodies were supplied by
SantaCruz and all secondary HRP conjugated antibodies were supplied by Sigma.
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4.18.  EQUIPMENT
The following equiments were routinely used during this study: Automatic pipettes
(Rainin), filter and 3MM paper (Whatman), GeneAmp PCR System 9600 (Perkin Elmer),
heating blocks (Stuarts Scientific), benchtop centrifuge (Heraus Instruments), Avanti J-25I
centrifuge (Beckman), gel tanks for agarose (E-C Apparatus Corporation), Mini-
PROTEAN 3 Cell (BioRad), spectrophotometer DU640 (Beckman), power supply PAC
300(BioRad), pH meter (Beckman), UV transilluminator (Herolab), Slab Gel Drier
(Savant), Mini Trans-Blot (Biorad).
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5.  RESULTS
5.1.  INTRODUCTION
Identification of the biological functions of the nuclear matrix protein C1D is
important, as it will possibly provide evidence of how nuclear matrix is involved in
regulation of cellular processes.  An equally important issue is to demonstrate the role of
DNA-PK in these events in connection with the nuclear matrix.  In an attempt to identify
the biological functions of C1D, a yeast two-hybrid system was employed to screen a
human B-lymphocyte cDNA library using the full-length open reading frame of C1D as
bait (Dincer et al. Bilkent University, unpublished).  In this system, a protein of interest is
expressed in fusion with a DNA-binding domain of a transcription factor lacking a
transcription activation domain (bait).  The yeast strains used for this purpose contain
reporter genes (LacZ and/or HIS3) with binding sites for this DNA-binding domain.
When expressed in the yeast, the bait plasmid will be able to bind to these specific
sequences in the promoter region of the reporter gene through its DNA-binding domain.
However, expression of the LacZ or HIS3 will not occur as this protein-DNA complex
lacks an activation domain.  The yeast strain carrying the bait plasmid is then transformed
with a cDNA library (or another protein of interest) expressed in fusion with an activation
domain.  Thus, if any of the proteins encoded by the cDNA interacts with the bait protein,
transcriptional activation will occur and the expression of the reporter genes is measured by
means of the β-galactosidase activity produced or growth capacity of yeast cells in the
absence of HIS3, both of which are direct indicators of interaction of two proteins.
53
The yeast two-hybrid screening using C1D as bait, revealed five cDNA groups
mainly encoding proteins involved in recombination and repair.  A search of the GenBank
database revealed that one group of overlapping sequences that derived from the same
cDNA encoded the TAFI 48 subunit of SL1.  In this study, we aimed to verify this
interaction and confirm that not only the partial cDNA sequences but the full-length
TAFI48 can also interact with C1D in various different in vivo and in vitro systems.
5.2.  CLONING OF TAFI 48 IN VARIOUS EXPRESSION PLASMIDS
The TAFI 48  full-length open reading frame was amplified using PCR and was
cloned into yeast, bacterial, mammalian and baculovirus expression plasmids as described
in Materials and Methods (4.8.7.).  The recombinant plasmids were checked by appropriate
restriction enzymes. Table 5.1 depicts the expression plasmids and the expected sizes using
the corresponding enzymes.  A sample digest is presented in fig.5.1.
                Table 5.1: Restriction Mapping of the Constructs
VECTOR DIGEST EXPECTED FRAGMENTS (bp)
TAFI 48-pACT2 EcoRI 760, 192
TAFI 48-pQE30 HindIII 610, 171
TAFI 48-T7-myc-pLink EcoRI 192
TAFI 48-pCMV EcoRI 400, 192
TAFI 48-pcDNA3.1 HindIII 622, 610
TAFI 48-pBlueBacHis2 HindIII 610
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Figure 5.1: Sample digest result
Lanes:
1- GeneRuler DNA Ladder Mix
2- TAFI 48-pACT2 digested with EcoRI
3- TAFI 48-pQE30 digested with HindIII
4- TAFI 48-T7-myc-pLink digested with EcoRI
5- TAFI 48-pCMV digested with EcoRI
6- TAFI 48-pcDNA3.1 digested with HindIII
7- TAFI 48-pBlueBacHis2 digested with HindIII
8- GeneRuler DNA Ladder Mix
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5.3.  CONFIRMATION OF C1D/TAFI 48 INTERACTION IN YEAST USING
ONPG ASSAY
 It is always possible that the partial cDNA clones obtained as a consequence of a
yeast two-hybrid screening could belong to another protein and/or might be translated to an
unrelated polypeptide.  It is essential therefore, to confirm the interaction using the full-
length proteins.  To establish this, the full-length open reading frame of TAFI 48 was
expressed in yeast as an activation domain tagged fusion protein (this fusion is referred to
as AD-TAF 48).  AD-TAF 48 (in pACT2) was transformed into the strain L40 together
with baits (in pBTM116) comprising the LexA DNA-binding domain (DBD) alone, DBD-
Lamin (DBD-La), DBD-Daughterless (DBD-Da), or DBD-C1D and the level of β-
galactosidase activity from the integrated LacZ reporter was determined in each case using
the ONPG assay.  As seen in Fig.5.2, TAFI 48 interacted specifically with C1D since no
interaction was detected with DBD alone, or with heterologous fusion proteins, DBD-
Lamin, or DBD-Daughterless.
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Figure 5.2: Yeast two hybrid assay.  β-galactosidase activity was measured using ONPG
as a substrate to determine the specificity of the interaction between C1D and TAFI 48.
5.4.  IN VITRO INTERACTION ASSAYS
 Having confirmed that C1D and TAFI 48 interact specifically in yeast, in vitro
assays were performed to determine whether these two proteins would also interact in vitro.
For this purpose, one approach would be to express and purify TAFI 48 in bacteria and
check its interaction with the purified C1D.  However, despite using various conditions
including different IPTG concentrations, induction at different temperatures for varying
time courses and by using different bacterial strains, it was not possible to express TAFI 48
in bacteria.  Therefore, another approach was taken towards immobilizing C1D on a
column and then performing the pull-downs with the in vitro transcribed and translated
TAFI 48 product.  Previous studies demonstrated that the bacterially expressed C1D was
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insoluble, however, could be purified under denaturing conditions followed by refolding in
the presence of DNA (Yavuzer et al. 1999).  In other words, it was impossible to keep C1D
in solution unless it was refolded on DNA.  In these old purification schemes, the
denatured C1D was first eluted from the column and then was refolded slowly against a
urea gradient in the presence of linear or supercoiled DNA.  However, for our purposes,
C1D had to be refolded and kept in solution while it was still immobilized on Ni-NTA
column.  It was also important to obtain purified C1D without having the DNA around as
this could give rise to non-specific interactions or interaction of two proteins through DNA
rather than direct protein-protein interaction.
5.4.1. Purification of His-Tagged C1D Protein Under Denaturing Conditions
C1D-pQE30 (provided by U. Yavuzer) was expressed in bacteria and purified under
denaturing conditions as described in materials and methods (Section 4.14.4.).  Unlike the
methods used in previous purification methods, the denatured protein was kept bound to
the column and was subjected to a linear urea gradient without adding DNA into the
refolding buffer.  The refolded C1D that was immobilized on Ni-NTA column was then
stored in 0.1x TE (containing protease inhibitors) for pull-down assays.  A little amount of
immobilized C1D was subjected to SDS-PAGE to check the purity and amount of the
bound protein.  As seen in Fig.5.3, a single protein band of expected molecular size (18
kDa) to C1D was detected, suggesting that the purification had been successful and that
enough amount of a soluble protein has been obtained.
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Figure 5.3: Ni-NTA immobilized C1D.  C1D immobilized on Ni-NTA column using the
modified method was detected by Coomassie staining after resolving the protein complexes
on SDS-PAGE.  M, is the protein size marker.
Next step was to demonstrate whether this protein would still be soluble after being
eluted from the column.  Another equally important issue was to show that this was the
actual C1D protein and not any other irrelevant protein with a similar size to C1D.  For this
purpose, the refolded protein was eluted from the column and the protein fractions were
resolved by SDS-PAGE followed by western blotting using a polyclonal antibody raised
against C1D.  Fig. 5.4 demonstrates that anti-C1D antibody recognizes the protein fractions
eluted from the column and that the new purification scheme that was used to refold C1D
in the absence of DNA has been successful.  A protein band around 32 kDa indicates that
eluted fractions contain C1D as concatamers that are extremely stable dimers of C1D.
5 µl 10 µl
Immobilized C1D
M
14 kDa
29 kDa
1 2 3
18 kDa
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Figure 5.4: Western blot detection of C1D. C1D bound to the Ni-NTA column was
eluted by Imidazole and the protein fractions were subjected to western blotting using an
antibody raised against C1D. Lane 1 is 30 µl of protein from fraction B, lanes 2 and 3
contain protein from fraction A of 15 µl and 30 µl, respectively.
5.4.2. Ni- NTA Pull-Down Assay
C1D that has been purified and refolded under the conditions described above was
then used for in vitro interaction assays.  For this purpose TAFI 48 was in vitro transcribed
and translated using the TnT Reticulocyte lysate system in a total volume of 50 µl.
Because S35-methionine is used in this process, it is possible to detect the proteins by
directly exposing the gels to autoradiography.
 Ni-NTA beads alone (Fig. 5.5 lane 4) or beads containing the immobilized C1D
(lane 3) were incubated with the in vitro transcribed and translated TAFI 48 product and
pull-down assays were performed as described in Materials and Methods (section 4.14.7.1).
Although there was a significant binding of TAFI 48 to C1D (lane 3), similar amount of
Blot: α- C1D
1 2 3
A
B
16 kDa
32 kDa C1D
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TAFI 48 was also seen to be bound by the Ni-NTA beads alone (lane 4), suggesting that
the in vitro interaction detected under these assay conditions is not specific.  Despite
several attempts by using more stringent conditions, it was not possible to eliminate the
affinity of TAFI 48 to Ni-NTA beads.  Although TAFI 48 does not contain a stretch of
histidine amino acids as such, it is possible that a small amino acid region within the TAFI
48 could recognize Ni-NTA and bound non-specifically.  Alternatively, the reticulocyte-
lysate could be the reason of this non-specificity.
Therefore, it was decided to use another column to immobilize C1D, with the hope
that TAFI 48 would not bind non-specifically.
Figure   5.5:  Ni-NTA pull-down assay.  In vitro transcribed and translated TAFI 48 (lane
2) was incubated with C1D immobilized on Ni-NTA (C1D-beads) (lane 3) and Ni-NTA
beads alone (lane 4) and pull-down assay was performed.  The bands were visualized by
autoradiography. M, is the protein size marker.
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5.4.3.  Purification of GST-C1D Protein Under Non-denaturing Conditions
For this new approach, widely used glutathione sepharose system for in vitro
interaction assays was chosen.  As a first attempt, C1D was expressed in bacteria in fusion
with GST (GST-C1D, provided by U. Yavuzer).  GST on its own was also expressed and
purified under the same conditions as GST-C1D.  Interestingly, C1D expressed in fusion to
GST is soluble (Yavuzer et al. 1998).  Figure 5.6 shows the purification result where the
proteins bound to sepharose beads were mainly GST and GST-C1D, with expected sizes of
27.5 kD and 45.5 kD respectively.
Figure 5.6:  Purification of GST and GST-C1D fusion proteins. GST- C1D and GST on
its own were expressed in bacteria and bound to glutathione sepharose beads.  The flow-
through (FT) from each column was spared after the first wash for detection of unbound
proteins.  The bound proteins (B) and FT fractions were resolved on SDS-PAGE and
visualized by Coomassie staining.
FT B FT B
GST GST- C1D
GST
GST-C1D
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5.4.4. GST Pull-Down Assays Using IVTT Product of TAFI 48.
The purified GST and GST-C1D were immobilized on glutathione beads and were
incubated with the in vitro transcribed and translated TAFI 48.  After extensive washing,
the protein complexes were resolved on SDS-PAGE and analyzed.  It was once again seen
that TAFI 48 bound to both GST and GST-C1D, albeit binding being about 5-fold stronger
to C1D than to that GST alone (Fig. 5.7, compare lanes 2 and 3).  Although this experiment
suggested that these two proteins interact in vitro as well, clearly the IVTT product of
TAFI 48 somehow shows affinity towards both Ni-NTA and less strongly to GST.  Since
this could be an artifact due to reticulocycte lysate, it was decided to obtain TAFI 48 via
another route rather than using in vitro transcription and translation system.
Figure 5.7: GST pull-down assay using IVTT product of TAFI 48.  IVTT product of
TAFI 48 was incubated with GST (lane 2) and GST-C1D (lane 3) immobilized on
glutathione beads and the complexes were resolved on SDS-PAGE and visualized by
autoradiography.
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5.4.5. GST-Pull-Down Assay Using TAFI 48 Expressed in Mammalian Cells
For this purpose, a mammalian cell line, COS7, was transiently transfected with a
plasmid expressing TAFI 48.  As an HA-epitope was placed to the N-terminal region of
TAFI 48, it was possible to detect the expression of the protein using an antibody raised
against the HA epitope.  After 30 hours following transfection, total cell lysates were
prepared from cells transfected with TAFI 48-pCMV.  These lysates were then incubated
with the immobilized GST and GST-C1D and pull-down assays were performed as
described before.  After resolving the protein complexes on SDS-PAGE, the proteins were
transferred to nitrocellulose and western blotting was performed using an antibody against
HA epitope.  As seen in Fig. 5.8 lane 1, the immobilized GST alone did not bind any
protein from the cell lysate.  However a protein band of expected molecular size for HA-
TAFI 48 was readily detectable when GST-C1D was incubated with the TAFI 48-pCMV
transfected cell lysate (lane 2).  To confirm that observed protein band is HA-TAFI 48, the
lysates from untransfected and TAFI 48-pCMV transfected cells were immunoprecipitated
using anti-HA antibody.  The protein complexes obtained by immunoprecipitation were
also run along the GST/GST-C1D pull-downs and probed with anti-HA antibody.  As
presented in lane 3, the protein bound to GST-C1D in lane 2, is not present in lysates from
untransfected cells but is detectable in the immunocomplexes precipitated from the
transfected cell lysate, indicating that the protein complex that was bound to GST-C1D is
HA-TAFI 48.
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Figure 5.8: GST pull-down assay using TAFI 48 expressed in mammalian cells.
Lanes 1 and 2 are the immobilized GST and GST-C1D on glutathione beads incubated with
the cell lysate from HA-TAFI 48 transfected cells.  Lanes 3 and 4 are the cell lysates from
untransfected and HA-TAFI 48 transfected cells immunoprecipitated with anti-HA
antibody.  The complexes were resolved on SDS-PAGE, transferred to nitrocellulose and
probed with anti-HA antibody.
5.5.  KINASE ASSAYS
The in vivo and in vitro interaction between one of the subunits of SL1, which is
involved in Pol I transcription, and C1D is potentially interesting because of their mutual
connection with DNA-PK.  Since the molecular mechanisms underlying the role of DNA-
PK in the repair of DSBs are not known, it is possible that this new interaction might
provide some evidence towards identification of these mechanisms.  It was important
therefore, to set up a functional assay to have an idea about the possible biological
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consequences of interaction between C1D and TAFI 48.  One possible mechanism, DNA-
PK could phosphorylate TAFI 48 either directly or by the aid of C1D.  However, before
performing this experiment it was necessary to demonstrate that C1D protein that has been
purified using the modified method behaves similar to C1D obtained by traditional
methods.  Since C1D is known to be a very efficient substrate for DNA-PK, in vitro DNA-
PK kinase assays were performed using C1D purified and refolded in the absence of DNA.
In this assay purified DNA-PKcs, Ku (kindly provided by S.Jackson) and C1D proteins
were incubated in the presence of [γ32-ATP].  As being a kinase, DNA-PKcs together with
Ku would transfer the radioactively labeled ATP onto C1D, enabling us to detect the
protein by autoradiography, if it is being phosphorylated.
In agreement with the previous studies, DNA-PKcs did not have any kinase activity
in the absence of Ku subunit or DNA (Fig. 5.9 lanes 1 and 2) and when linear DNA was
included, the autophosphorylation was detected (lane 3).  On the other hand, the C1D that
was purified in the absence of DNA was phosphorylated as efficiently as the C1D purified
by other methods using DNA for refolding.
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Figure 5.9: In Vitro kinase assay.  C1D purified with the modified method was incubated
with DNA-PK in the presence of [γ32-ATP] and the phosphorylated proteins were detected
by autoradiography. The autophosphorylated DNA-PKcs and phosphorylated C1D is
indicated by arrow heads.
After having demonstrated that C1D purified with our modified method is also a
substrate for DNA-PK, TAFI 48 was checked for being phosphorylated by DNA-PK in the
absence or presence of C1D.  For this purpose, the COS7 cells were transiently transfected
with TAFI 48 and cell lysates were immunoprecipitated using anti-HA antibody as
described before. The immune-complex was then subjected to kinase assay in the presence
of [γ32-ATP].  As a positive control, the well-known substrate for DNA-PK was also
included (Fig 5.10 lane 6).  The cell lysate from cells expressing the HA-epitope was
immunoprecipitated with anti-HA antibody and was also subjected to kinase assay to
+ + + + +
- + + + +
- - - + +
- - + + +
1 2 3 4 5
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C1D
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demonstrate that the reaction is not inhibited by the cell lysates. As demonstrated in Fig
5.10, both the autophosphorylation of DNA-PKcs (lanes 1 and 2) and phosphorylation of
C1D (lane 3) could be detected and the presence of cell lysate immunoprecipitated with the
HA-antibody did not affect the phosphorylation of either of the proteins (lanes 2 and 3).  In
lane 4, anti-HA antibody immunoprecipitate from HA-TAFI 48 transfected cell lysates
were assayed for phosphorylation by DNA-PK.  As clearly seen, DNA-PK was not able to
phosphorylate TAFI 48 on its own.  Next, the same reaction was repeated in the presence
of C1D, and again DNA-PK failed to phosphorylate TAFI 48, although phosphorylation of
C1D was readily detectable (Lane 5).  Therefore, it was concluded that, C1D purified by
our modified method was an efficient substrate for DNA-PK, however, DNA-PK failed to
phosphorylate TAFI 48 either in the absence or presence of C1D.
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Figure 5.10: Immune-complex Kinase Assay.  COS 7 cells were transiently transfected
with plasmids expressing either HA-TAFI 48 or HA-epitope.  The cell lysates were
immunoprecipitated with anti-HA antibody and the immune-complexes were subjected to
kinase assay using purified DNA-PK and C1D.  All reactions contained 50 ng of linear
plasmid DNA.
5.6. TAFI 48/C1D INTERACTION IN MAMMALIAN CELLS
We also wished to test whether C1D and TAFI 48 are capable of interacting with
one another in mammalian cells. COS7 cells were transiently transfected with a plasmid
expressing HA-epitope tagged C1D (C1D-pCMV, provided by U. Yavuzer).. 30 hours
following transfection, cell lysates were prepared from transfected and untransfected cells
and immunoprecipitated with an anti-HA antibody. The immunoprecipitates were then
analyzed by western blotting using anti-TAFI 48 antibody. As shown in Fig. 5.11A, TAFI
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48 immunoprecipitated with HA-C1D, although the interaction seemed to be rather weak.
To demonstrate that, this weak interaction is not due to the inefficient immunoprecipitation
of HA-C1D, the membrane was stripped and re-probed with the anti-HA antibody.
Fig.5.11B demonstrates that HA-C1D is immunoprecipitated very efficiently from the
transfected but not untransfected cells.   Another reason for this weak interaction could be
that the band detected with the anti-TAFI 48 antibody is not specific and the antibody
could be recognizing an irrelevant protein from the cell lysate.  To eliminate this
possibility, the membrane was stripped for the third time and re-probed with anti-TAFI 48
antibody that has been incubated with an antibody specific peptide for 2 hours.  If the
detected protein band in Fig.5.11A was really TAFI 48, then we would expect this band to
disappear after probing with the neutralized antibody.  In Fig 5.11C, it is shown that,
although there was a decrease in the intensity of the band, it did not disappear completely.
Nevertheless, because the neutralized antibody inhibited the detection of TAFI 48 to an
extent, it was concluded that C1D and TAFI 48 may interact in mammalian cells, however,
rather weakly under physiological conditions.
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Figure 5.11: Immunoprecipitations from mammalian cells.   A) Untransfected and HA-
C1D transfected cells were immunoprecipitated with the indicated antibody and probed
with the anti-TAFI 48 antibody to check for the interaction between C1D and the
endogeneous TAFI 48.  B) The mebrane was stripped and re-probed with anti-HA
antibody. C) The mebrane was re-stripped and probed with the neutralized TAFI 48
antibody.
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6.  DISCUSSION
First described by Brown in 1831, the cell nucleus is one of the best known but
least understood of cellular organelles.  Current evidence suggests that the nucleus is
spatially ordered by attachments to a non-chromatin nuclear structure, the nuclear matrix
(Nickerson et al. 1995). The nuclear scaffolding juxtaposes factors, enzymes, and other
macromolecules in appropriate spatial domains of the nucleus, thereby effecting an
efficient assembly of the complexes involved in replication, transcription, and RNA
processing. The nuclear matrix binds most nuclear RNA and organizes chromatin
attachment sites responsible for chromatin loops.  Many of the intermediates of nucleic
acid metabolism, together with regulatory and catalytic factors, remain complexed to the
nuclear matrix when separated from chromatin.  This and other evidence suggest that
nucleic acid synthesis and processing are both nuclear matrix-bound processes (Nickerson
et al. 1995; Van Driel et al. 1995; Berezney et al. 1995).
Nuclear matrix contains 10-25% of the total nuclear protein and nuclear matrix
proteins are the nonhistone proteins that are tightly bound to DNA even after treatment
with harsh denatures (Neuer et al. 1983).  These nonhistone proteins have a heterogeneous
profile and include cell type and differentiation state-specific proteins as well as common
proteins termed the nuclear matrins.
The nuclear matrix protein C1D is the first of such non-histone proteins to have
been characterized at the sequence level (Nehls et al. 1998).  In an independent research,
C1D was found to be associated with the transcriptional repressor RevErb and the nuclear
co-receptors, indicating that it could act as a component of the complex involved in
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transcriptional repression (Zamir et al. 1997). C1D has also been shown to induce
apoptosis in a p53 dependent manner (Rothbarth et al. 1999) in agreement with the
function of DNA-PK as an upstream effector for p53 activation in response to IR, linking
DNA damage to apoptosis (Wang et al. 2000). Together with these observations when its
interaction with DNA-PK and possible involvement in DNA repair is considered, we can
say that C1D is a multifunctional protein.  Attempts towards identification of the biological
function of C1D led to the isolation of TAFI 48 as an interacting protein with C1D.
Because the Pol I transcription is repressed by DNA-PK by an unknown, but
phosphorylation dependent mechanism, we believe that this interaction will provide a
starting point towards revealing the molecular mechanisms DNA-PK undertakes while
performing its functions.
In this study, we demonstrated that C1D and TAFI 48 interact in yeast, in
mammalian cells and in vitro specifically, although the interaction between C1D and TAFI
48 seems to be weak with respect to other C1D interacting proteins.
TAFI 48 is a good candidate for recruiting modifying complexes to Pol I promoters
because the binding of TAFI 48 to TBP is sufficient to block or conformationally alter the
DNA binding surface of TBP in a manner that prevents recognition of the TATA-box
element (Beckmann et al. 1995), which means that TAFI 48 is the major determinant in Pol
I promoter selectivity.  In addition, TAFI 48 serves as a target for interaction with UBF and
is required to form a transcriptionally active SL1 complex responsive to UBF in vitro
(Beckmann et al. 1995).
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 A weak interaction between C1D and TAFI 48 under normal physiological
conditions would be meaningful if this interaction is expected to play a role in repression of
Pol I transcription in response to certain exogenous stimuli such as γ-irradiation.
The data obtained so far enables us to propose two hypothetical models on how
polymerase I transcription could be repressed by DNA-PK.  In one model, the normally
weak interaction between C1D and TAFI 48 would be enhanced in response to DNA
damaging agents inducing DNA double strand breaks.  Since DNA-PK is activated upon γ-
irradiation and can phosphorylate C1D in vitro, it is possible that in response to DNA
damage DNA-PK may get activated and as a consequence may phosphorylate C1D in vivo.
This post- translational modification may enhance the affinity of C1D towards TAFI 48.  In
this work, chemicals such as MMS or etoposide were used to induce DNA double strand
breaks, with the hope that the weak interaction detected in co-immunoprecipitation
experiments could be enhanced.  The problem with these experiments is that the dose and
duration of the application of the chemical and also the time point when the DNA double
strand breaks are induced vary according to the cell type.  In our case although many
different conditions were used, it was not possible to induce the interaction between C1D
and TAFI 48 any further.  Nevertheless, this does not rule out the possibility that C1D and
TAFI 48 may interact in response to agents inducing DNA double strand breaks.
Application of direct X-rays using a gamma irradiation source may overcome this problem.
Unfortunately, this experiment was not performed as an irradiation source is not available
in this department.  The DNA-PK induced interaction between C1D and TAFI 48 in
response to DNA damage may be important as this complex may hinder the formation of
SL1 on the the rRNA promoter and thus, inhibit polymerase I transcription.
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Alternatively, C1D/TAFI 48 interaction may act to recruit activated DNA-PK to
rRNA synthesis sites and DNA-PK may then phosphorylate C1D, TAFI 48 or another
subunit of  SL1 to inhibit the transcription. TAFI 48 is a good candidate for
phosphorylation by DNA-PK as it is possible that phosphorylation of TAFI 48 may disrupt
its interaction with UBF so that phosphorylated SL1 no more binds to rRNA promoter.
However, using the in vitro kinase assay with the highly purified DNA-PK, we were not
able to show the phoshorylation of TAFI 48 by DNA-PK.  Although the possibility still
exists that this phosphorylation event may take place in vivo, it is equally possible that
DNA-PK may target another subunit of SL1.  It is already known that that the transcription
of ribosomal RNA genes by RNA Polymerase I is inhibited by cdc2/cyclinB mediated
phosphorylation of TAFI 110 (Heix et al., 1998).  It would be of great interest to see if this
subunit is also regulated by DNA-PK in response to DNA damaging agents and hence
results in inhibition of Pol I transcription.
On the contrary to the first model where an indirect role for DNA-PK in repression
of Pol I transcription has been suggested, in the second model, a more direct role has been
proposed.  Nevertheless, these two models may not necessarily be mutually exclusive.  In
response to DNA damage, DNA-PK may repress rRNA transcription by using both direct
and indirect pathways.
6.1.  Future Perspectives
The finding that the nuclear matrix protein C1D interacts specifically with one of
the essential components of the Pol I transcription system no doubt provides evidence that
the nuclear matrix plays important roles in transcriptional regulation besides several other
76
cellular processes.   The important task now is to identify the functional and biological
significance of this interaction.  In other words, the experiments will be organized towards
proving or disproving the hypotheses proposed above.  One important thing to show will be
whether interaction between TAFI 48 and C1D really holds back the formation of SL1 on
to the promoter as suggested in the first model.  This experiment is rather easy to perform
providing that a pure TAFI 110, 63, 48 and TBP are obtained.  As mentioned before, it was
impossible to express TAFI 48 in bacteria.  The open reading frame of TAFI 48 has already
been cloned into a baculovirus expression plasmid and studies into expression and
purification of TAFI 48 in insect cells should be undertaken in the near future. The other
proteins can be expressed and purified in bacteria.  Once the pure proteins are obtained,
transcription factor SL1 could be reconstituted in the presence and/or absence of C1D to
determine whether the reconstituted complexes are as active in supporting transcription
from the human ribosomal RNA gene promoter as endogenous SL1.  In this context, it
would also be possible to perform the same experiments using the in vitro phosphorylated
C1D.
Another important issue is to demonstrate the role of phosphorylated versus
unphosphorylated C1D in Pol I transcription.  For this purpose an in vitro run on/off assay
could be used, ideally using highly purified Pol I basal transcription components.
However, in short term, just by using a baculovirus purified TAFI 48 and a TAFI 48
immunodepleted whole cell extract, it would be possible to detect the effects of various
forms of C1D on TAFI 48 and as a consequence, on in vitro transcription of Pol I.  Also the
efficiency of transcriptional inhibition by DNA-PK on circular templates in the presence or
absence of C1D could be checked with the in vitro transcription assays.
77
In order to obtain more solid evidence about the regulatory role of DNA-PK on
C1D/TAFI 48 complex and Pol I transcriptional repression, human cell lines wild type and
mutant for DNA-PK could be exposed to γ-irradiation and the interaction between C1D and
TAFI 48 and the rRNA levels could be checked. The cells could be synchronized to
examine if the regulation is cell cycle dependent. Also in these cells, the colocalization of
TAFI 48, C1D and DNA-PK could be checked by immunofluorescence.  It will be an idea
to knock-out C1D on the wild type and check whether there will be any alterations in the
Pol I transcription levels when cells are exposed to γ-irradiation.
In conclusion, in this work, the interaction of two proteins have been verified, and
now it is time to find an answer to the questions why and how these proteins interact under
biological conditions.
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